Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06841731 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Trial of HRS-8427 in the Treatment of Adults With Bacterial Pneumonia

StatusActive, Not Recruiting
PhasePhase 2
Started2025-04-10
View on ClinicalTrials.gov ↗

Amendment history

2026-10-01
notable
Enrollment closed, study ongoing
Final enrollment: 120 participants (planned 100)
Primary completion 2026-09-22, at least 206 days after the final estimate of 2026-02
Completion pushed: 2026-02 → 2026-10
2025-04-21
notable
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2025-03→confirmed 2025-04-03
Study sitesdetails revised at 1 of 1 site
2025-02-19
minor
Original filing
The purpose of this study is to evaluate the efficacy and safety of HRS -8427 in patients with HABP/VABP.
Trial Details
NCT Number NCT06841731
Lead Sponsor Jiangsu HengRui Medicine Co., Ltd.
Conditions Hospital-acquired Bacterial Pneumonia (HABP), Ventilator-associated Bacterial Pneumonia (VABP)
Enrollment 120 participants
Start Date 2025-04-10
Primary Completion 2026-09-22 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2026-09-30